Target intelligence / Profile preview

Long noncoding RNA regulator of monocyte proliferation (LNCRMP)

Target
LNCRMP
Molecular classification
Long noncoding RNA (lncRNA), Non-protein-coding RNA
01

Overview

Long noncoding RNA regulator of monocyte proliferation (LNCRMP) is a human long noncoding RNA essential for monocyte proliferation and survival[2][3]. LNCRMP is situated adjacent to the IRF8 gene, a transcription factor key to monocyte/macrophage development, and regulates IRF8 in cis. Knockdown of LNCRMP in the THP-1 monocyte cell line results in markedly decreased cell growth and viability, mainly via decreased IRF8 expression and activation of proapoptotic gene expression programs. Genome accessibility and isoform expression data indicate that LNCRMP is expressed at low levels in resting monocytes, with highest expression upon macrophage activation. There is currently no evidence for direct pharmacological targeting, but LNCRMP serves as a functional noncoding RNA target controlling monocyte homeostasis and may have implications in diseases involving monocyte dysregulation such as lupus[2][3].

Other names
LNCRMPRP11-542M13.2 (the annotated genetic locus)Long noncoding RNA regulator of monocyte proliferation
02

Mechanism of action

Not targeted by drugs; acts chiefly by cis-regulating IRF8, a protein coding gene critical for monocyte survival

03

Biological functions

Regulation of monocyte proliferationRegulation of apoptosis (via influence on proapoptotic pathways)Cis-regulation of adjacent protein-coding genes (notably IRF8)Likely impacts on broader immune cell viability and homeostasis
04

Disease associations

Inflammation (through monocyte growth control)Potential roles in autoimmune disorders (such as lupus, via regulation of IRF8)Other (no evidence yet for cancer, neurodegeneration, etc.)
05

Safety considerations

Knockdown of LNCRMP leads to loss of monocyte proliferation and viability; untargeted inhibition could cause immune suppression or cytopeniasNo drug safety data known
06

Interacting drugs

None known
07

Biomarkers

LNCRMP expression may serve as a biomarker for monocyte proliferative stateIRF8 expression (due to its regulation by LNCRMP)

Beyond the preview

Go deeper on Long noncoding RNA regulator of monocyte proliferation (LNCRMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long noncoding RNA regulator of monocyte proliferation (LNCRMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call